Silver Book Fact

AFib treatment costs, 2001

In 2001, the estimated treatment costs of atrial fibrillation were $6.65 billion per year—this included hospitalization costs, in- and out-patient care, and medications. This did not include costs of stroke prevention treatments, inpatient drug costs, inpatient physician fees, or indirect costs.

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • AFib-related stroke and disability
    Stroke is very disabling and individuals recovering from a stroke who also have AFib have a higher risk of remaining disable or handicapped compared to stroke patients without AFib.  
  • Atrial fibrillation doubles mortality risk
    Atrial fibrillation is associated with an approximate doubling of mortality risk.  
  • Medicare beneficiaries AFib mortality rate
    Of Medicare beneficiaries who receive an atrial fibrillation diagnosis, 1 in 4 will die within a year.  
  • Hospitalization costs for patients with nonrecurrent ischemic stroke
    The cost of hospitalization for patients with nonrecurrent ischemic stroke is $4,991 more in patients with atrial fibrillation, than in patients without the disease.        
  • AFib prevalence projected to double by 2050
    By 2050, the prevalence of atrial fibrillation will have more than doubled since 2001—growing to an estimated 5.6 million to 12.1 million Americans.